BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31404982)

  • 21. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells.
    Belguise K; Guo S; Sonenshein GE
    Cancer Res; 2007 Jun; 67(12):5763-70. PubMed ID: 17575143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting DNA methylation with green tea catechins.
    Yiannakopoulou EC
    Pharmacology; 2015; 95(3-4):111-6. PubMed ID: 25792496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.
    Kim J; Zhang X; Rieger-Christ KM; Summerhayes IC; Wazer DE; Paulson KE; Yee AS
    J Biol Chem; 2006 Apr; 281(16):10865-75. PubMed ID: 16495219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells.
    Lubecka K; Kaufman-Szymczyk A; Cebula-Obrzut B; Smolewski P; Szemraj J; Fabianowska-Majewska K
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
    Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
    Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Green tea polyphenol EGCG reverse cisplatin resistance of A549/DDP cell line through candidate genes demethylation.
    Zhang Y; Wang X; Han L; Zhou Y; Sun S
    Biomed Pharmacother; 2015 Feb; 69():285-90. PubMed ID: 25661371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer.
    Negri A; Naponelli V; Rizzi F; Bettuzzi S
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids.
    Lee WJ; Shim JY; Zhu BT
    Mol Pharmacol; 2005 Oct; 68(4):1018-30. PubMed ID: 16037419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
    Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo.
    Tran PL; Kim SA; Choi HS; Yoon JH; Ahn SG
    BMC Cancer; 2010 Jun; 10():276. PubMed ID: 20537126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins.
    Kuzuhara T; Tanabe A; Sei Y; Yamaguchi K; Suganuma M; Fujiki H
    Mol Carcinog; 2007 Aug; 46(8):640-5. PubMed ID: 17440927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
    Ahmad N; Gupta S; Mukhtar H
    Arch Biochem Biophys; 2000 Apr; 376(2):338-46. PubMed ID: 10775421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells.
    Moseley VR; Morris J; Knackstedt RW; Wargovich MJ
    Anticancer Res; 2013 Dec; 33(12):5325-33. PubMed ID: 24324066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigallocatechin gallate induces the steady state mRNA levels of pS2 and PR genes in MCF-7 breast cancer cells.
    Manjegowda CM; Deb G; Limaye AM
    Indian J Exp Biol; 2014 Apr; 52(4):312-6. PubMed ID: 24772933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Propolis and Phenolic Acids on Triple-Negative Breast Cancer Cell Lines: Potential Involvement of Epigenetic Mechanisms.
    Assumpção JHM; Takeda AAS; Sforcin JM; Rainho CA
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32178333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells.
    Kato K; Long NK; Makita H; Toida M; Yamashita T; Hatakeyama D; Hara A; Mori H; Shibata T
    Br J Cancer; 2008 Aug; 99(4):647-54. PubMed ID: 18665171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells.
    Braicu C; Gherman CD; Irimie A; Berindan-Neagoe I
    J Nanosci Nanotechnol; 2013 Jan; 13(1):632-7. PubMed ID: 23646788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
    Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
    Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGCG Prevents High Fat Diet-Induced Changes in Gut Microbiota, Decreases of DNA Strand Breaks, and Changes in Expression and DNA Methylation of
    Remely M; Ferk F; Sterneder S; Setayesh T; Roth S; Kepcija T; Noorizadeh R; Rebhan I; Greunz M; Beckmann J; Wagner KH; Knasmüller S; Haslberger AG
    Oxid Med Cell Longev; 2017; 2017():3079148. PubMed ID: 28133504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.